BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21849771)

  • 1. Complete remission with a combination of lenalidomide, cyclophosphamide and prednisolone in a patient with incomplete POEMS syndrome.
    Suyanı E; Yağcı M; Sucak GT
    Acta Haematol; 2011; 126(4):199-201. PubMed ID: 21849771
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis].
    Adam Z; Pour L; Krejčí M; Zahradová L; Szturz P; Koukalová R; Rehák Z; Nebeský T; Hájek R; Král Z; Mayer J
    Vnitr Lek; 2012 Nov; 58(11):856-66. PubMed ID: 23256832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lenalidomide as frontline therapy in polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes syndrome: a retrospective case series of eight patients.
    Lestang E; Caristan A; Néel A; Graveleau J; Duhamel E; Masseau A; Connault J; Maisonneuve H; Le Gouill S; Blin N; Touzeau C; Moreau P; Hamidou M
    Leuk Lymphoma; 2015 Jun; 56(6):1895-6. PubMed ID: 25347429
    [No Abstract]   [Full Text] [Related]  

  • 4. Lenalidomide therapy in a rare case of POEMS syndrome with kappa restriction.
    Sethi S; Tageja N; Arabi H; Penumetcha R
    South Med J; 2009 Oct; 102(10):1092-3. PubMed ID: 19738540
    [No Abstract]   [Full Text] [Related]  

  • 5. Lenalidomide therapy in a patient with POEMS syndrome.
    Dispenzieri A; Klein CJ; Mauermann ML
    Blood; 2007 Aug; 110(3):1075-6. PubMed ID: 17644745
    [No Abstract]   [Full Text] [Related]  

  • 6. POEMS syndrome: diagnostic delay and successful treatment with lenalidomide, cyclophosphamide and prednisone followed by autologous peripheral stem cell transplantation.
    Ordway S; Gilbert L; Wanko S
    BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30054320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophilia secondary to lenalidomide therapy.
    Escudero-Vilaplana V; Osorio-Prendes S; Collado-Borrell R; González-Arias E; Sanjurjo-Sáez M
    J Clin Pharm Ther; 2018 Apr; 43(2):273-275. PubMed ID: 28833364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide for POEMS syndrome.
    Kim SY; Lee SA; Ryoo HM; Lee KH; Hyun MS; Bae SH
    Ann Hematol; 2006 Aug; 85(8):545-6. PubMed ID: 16718498
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful bortezomib-based treatment in POEMS syndrome.
    Tang X; Shi X; Sun A; Qiu H; Gu B; Zhou H; Xue S; Liu Y; Ruan C; Wu D
    Eur J Haematol; 2009 Dec; 83(6):609-10. PubMed ID: 19674063
    [No Abstract]   [Full Text] [Related]  

  • 10. POEMS syndrome: a case report.
    Ozden A; Süleyman Z; Seven G; Arat M; Akin A; Sener O; Kuzu I; Keven K; Ensari A; Erden A; Tan E
    Turk J Gastroenterol; 2008 Dec; 19(4):276-80. PubMed ID: 19119489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial.
    Nozza A; Terenghi F; Gallia F; Adami F; Briani C; Merlini G; Giordano L; Santoro A; Nobile-Orazio E
    Br J Haematol; 2017 Dec; 179(5):748-755. PubMed ID: 29048107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lenalidomide in patients with POEMS syndrome: a systematic review and pooled analysis.
    Zagouri F; Kastritis E; Gavriatopoulou M; Sergentanis TN; Psaltopoulou T; Terpos E; Dimopoulos MA
    Leuk Lymphoma; 2014 Sep; 55(9):2018-23. PubMed ID: 24295131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of lenalidomide in POEMS syndrome: a retrospective study of 20 patients.
    Royer B; Merlusca L; Abraham J; Musset L; Haroche J; Choquet S; Leleu X; Sebban C; Decaux O; Galicier L; Roussel M; Recher C; Banos A; Guichard I; Brisseau JM; Godmer P; Hermine O; Deplanque G; Facon T; Asli B; Leblond V; Fermand JP; Marolleau JP; Jaccard A
    Am J Hematol; 2013 Mar; 88(3):207-12. PubMed ID: 23335406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell collection in patients with multiple myeloma: impact of induction therapy and mobilization regimen.
    Nazha A; Cook R; Vogl DT; Mangan PA; Gardler M; Hummel K; Cunningham K; Luger SM; Porter DL; Schuster S; O'Doherty U; Siegel D; Stadtmauer EA
    Bone Marrow Transplant; 2011 Jan; 46(1):59-63. PubMed ID: 20421869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lenalidomide Treatment for Thalidomide-refractory POEMS Syndrome: A Prospective Single-arm Clinical Trial.
    Suichi T; Misawa S; Nagashima K; Sato Y; Iwai Y; Katayama K; Sekiguchi Y; Shibuya K; Amino H; Suzuki YI; Tsuneyama A; Nakamura K; Kuwabara S
    Intern Med; 2020 May; 59(9):1149-1153. PubMed ID: 32009091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving role of novel agents for maintenance therapy in myeloma.
    Magarotto V; Palumbo A
    Cancer J; 2009; 15(6):494-501. PubMed ID: 20010169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Two cases of POEMS syndrome with increased vascular endothelial growth factor (VEGF)].
    Arimura H; Watanabe O; Arimura K; Maruyama I; Hokezu Y
    Rinsho Shinkeigaku; 1997 Sep; 37(9):817-23. PubMed ID: 9430997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. POEMS syndrome: a challenging diagnosis of a rare disease.
    Creamer A; Gaastra B; Odogwu S; Whitelaw B
    Br J Hosp Med (Lond); 2014 Jul; 75(7):408-9. PubMed ID: 25040523
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase I trial of first-line bortezomib/thalidomide plus chemotherapy for induction and stem cell mobilization in patients with multiple myeloma.
    Badros A; Goloubeva O; Fenton R; Rapoport AP; Akpek G; Harris C; Ruehle K; Westphal S; Meisenberg B
    Clin Lymphoma Myeloma; 2006 Nov; 7(3):210-6. PubMed ID: 17229337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide in POEMS syndrome: case report.
    Sinisalo M; Hietaharju A; Sauranen J; Wirta O
    Am J Hematol; 2004 May; 76(1):66-8. PubMed ID: 15114600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.